​

Lyra Therapeutics (LYRA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Lyra Therapeutics Revenue Highlights

Latest Revenue (Y)

$1.53M

Latest Revenue (Q)

$25.00K

Lyra Therapeutics Revenue by Period

Lyra Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$1.53M-1.54%
2023-12-31$1.56M14.31%
2022-12-31$1.36M378.25%
2021-12-31$285.00K100.00%
2020-12-31-100.00%
2019-12-31--100.00%
2018-12-31$1.24M-

Lyra Therapeutics generated $1.53M in revenue during NA 2024, up -1.54% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Lyra Therapeutics Revenue by Quarter

DateRevenueChange
2025-09-30$25.00K-86.34%
2025-06-30$183.00K-
2025-03-31$183.00K-12.44%
2024-12-31$209.00K7.18%
2024-09-30$195.00K-67.39%
2024-06-30$598.00K12.41%
2024-03-31$532.00K264.38%
2023-12-31$146.00K-73.16%
2023-09-30$544.00K18.78%
2023-06-30$458.00K11.71%
2023-03-31$410.00K3627.27%
2022-12-31$11.00K-96.94%
2022-09-30$359.00K-31.62%
2022-06-30$525.00K12.18%
2022-03-31$468.00K72.69%
2021-12-31$271.00K1835.71%
2021-09-30$14.00K100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--

Lyra Therapeutics generated $25.00K in revenue during Q3 2025, up -86.34% compared to the previous quarter, and up 4.18% compared to the same period a year ago.

Lyra Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BOLTBolt Biotherapeutics$7.69M$2.17M
HCWBHCW Biologics$2.57M$15.61K
LYRALyra Therapeutics$1.53M$25.00K
CDIOCardio Diagnostics$2.02K$2.85K
GLTOGalecto--
CINGCingulate--
RNAZTransCode Therapeutics--
INABIN8bio--
CLRBCellectar Biosciences--
APVOAptevo Therapeutics--

LYRA Revenue FAQ

What is Lyra Therapeutics’s yearly revenue?

Lyra Therapeutics's yearly revenue for 2024 was $1.53M, representing a decrease of -1.54% compared to 2023. The company's yearly revenue for 2023 was $1.56M, representing an increase of 14.31% compared to 2022. LYRA's yearly revenue for 2022 was $1.36M, representing an increase of 378.25% compared to 2021.

What is Lyra Therapeutics’s quarterly revenue?

Lyra Therapeutics's quarterly revenue for Q3 2025 was $25K, a -86.34% decrease from the previous quarter (Q2 2025), and a -87.18% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $183K, a 0% increase from the previous quarter (Q1 2025), and a -69.40% decrease year-over-year (Q2 2024). LYRA's quarterly revenue for Q1 2025 was $183K, a -12.44% decrease from the previous quarter (Q4 2024), and a -65.60% decrease year-over-year (Q1 2024).

What is Lyra Therapeutics’s revenue growth rate?

Lyra Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 12.55%, and for the last 5 years (2020-2024) was 0%.